Duane Morris LLP and the American Trade Association for Cannabis & Hemp (ATACH) today announced the first-ever partnership agreement between an American Lawyer (Am Law) 100 law firm and a cannabis trade association. Duane Morris LLP is a law firm with more than 800 attorneys in offices across the United States and internationally. It marks the largest and most significant law firm partnership with a cannabis trade association to date.
The inaugural list honors individuals “who are involved in all areas of cannabis law from helping regulate the marketing to providing licensing to new companies.” Duane Morris is one of only three Am Law 100 firms represented on the list.
To read the full press release, please visit the Duane Morris website.
A video replay of the webinar “Hot Topics for Healthcare Facilities and the Utilization of Medical Cannabis” is available to view.
Duane Morris partner David N. Feldman, of the New York office, was interviewed by the Cannabis Financial Network Media Group discussing the firm’s cannabis practice at Kahner Global’s 2018 Cannabrunch, held during the 4th Annual Cannabis Private Investment Summit hosted by the New York office on September 13.
Duane Morris partner Michael Schwamm will present on “Investing in the Cannabis Industry” at the Opal Group Family Office & Private Wealth Management Forum West on October 25, 2018, in Napa, California.
Known for the fastest growing population of newly structured family offices in the world, Northern California is largely dominated by first and second-generation families from the Silicon Valley. Investment strategies such as Private Equity, Venture Capital, and Technology will be familiar themes throughout this conference. Investment managers and families will come together to discuss the foundations in which they built their wealth, and uncork the various investment strategies in which to keep their portfolios growing. For more information, visit the Opal Group website.
Duane Morris partner Jerome Levy will participate in the Strafford webinar, “Municipal Regulation of Marijuana: Guidance on Permitting, Licensing and Zoning for Medical and Recreational Uses,” on Wednesday, October 10, 2018, from 1:00 p.m. to 2:30 p.m. (Eastern time).
This CLE webinar will offer guidance to local government lawyers on regulating cannabis consumption for medical and recreational uses. The panel will discuss the patchwork of current regulatory efforts across the country and explore some of the most effective strategies for regulating in municipalities based on current case law and the interplay with state and federal regulation. For more information and to register, visit the Strafford website.
Even though cannabis remains a Schedule I controlled substance under U.S. federal law, the United States Patent Office (USPTO), a federal agency of the U.S. Department of Commerce, routinely grants patents covering cannabis-related technologies. The Schedule I classification of cannabis is not relevant to patentability. As with any other invention, to be patentable, a cannabis-related invention must be new, useful, and nonobvious, and teach one of ordinary skill in the art how to make and use the invention. The USPTO has determined that many cannabis-related patent applications have met these requirements. Patents granted to cannabis-related inventions cover an enormous range of technologies, including cannabis plants, growing systems, extracts, methods of making extracts, foodstuffs, veterinary products, and methods of treating various diseases and disorders.
Duane Morris partner David Feldman writes a monthly column for Honeysuckle Magazine. His latest column, “UK Goes for Medical: The Changing Status of Worldwide Weed,” is now available.
A video replay of the webinar “Cannabis 107: The U.S. and Canadian Cannabis Markets: 2018 Mid-Year Review” is available to view.
By David Landau
On Friday June 22nd, Pennsylvania Governor Tom Wolf signed into law a bill allowing Pennsylvania’s Medical Marijuana clinical research program to proceed. A Pennsylvania court a short while ago enjoined the program. Continue reading Pennsylvania Legislature Rescues Medical Marijuana Clinical Research Program